USD 2.67
(0.0%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 1.00 USD | 0.0% |
2022 | - USD | -100.0% |
2021 | 2.00 USD | 0.0% |
2020 | - USD | 0.0% |
2019 | - USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | -100.0% |
2015 | 327.44 Thousand USD | -13.04% |
2014 | 376.52 Thousand USD | 28.6% |
2013 | 292.79 Thousand USD | 39.51% |
2012 | 209.87 Thousand USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | 0.0% |
2009 | - USD | 0.0% |
2008 | - USD | 0.0% |
2007 | - USD | 0.0% |
2006 | - USD | 0.0% |
2005 | - USD | 0.0% |
2004 | - USD | 0.0% |
2003 | - USD | 0.0% |
2002 | - USD | -100.0% |
2001 | 364.98 Thousand USD | -7.95% |
2000 | 396.49 Thousand USD | -0.88% |
1999 | 400 Thousand USD | -20.0% |
1998 | 500 Thousand USD | 0.0% |
1997 | 500 Thousand USD | 150.0% |
1996 | 200 Thousand USD | -33.33% |
1995 | 300 Thousand USD | 50.0% |
1994 | 200 Thousand USD | 100.0% |
1993 | 100 Thousand USD | 0.0% |
1992 | 100 Thousand USD | 0.0% |
1991 | 100 Thousand USD | 0.0% |
1990 | 100 Thousand USD | 0.0% |
1989 | - USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | - USD | 0.0% |
2024 Q1 | - USD | -100.0% |
2023 Q1 | - USD | 0.0% |
2023 FY | 1.00 USD | 0.0% |
2023 Q4 | 1.00 USD | 0.0% |
2023 Q3 | 1.00 USD | 0.0% |
2023 Q2 | 1.00 USD | 0.0% |
2022 Q4 | - USD | -100.0% |
2022 Q2 | 1.00 USD | 0.0% |
2022 Q1 | - USD | -100.0% |
2022 FY | - USD | -100.0% |
2022 Q3 | 1.00 USD | 0.0% |
2021 Q4 | 2.00 USD | 0.0% |
2021 Q2 | - USD | -100.0% |
2021 FY | 2.00 USD | 0.0% |
2021 Q1 | 1.00 USD | 0.0% |
2021 Q3 | - USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2020 Q4 | - USD | -100.0% |
2020 FY | - USD | 0.0% |
2020 Q2 | 1.00 USD | 0.0% |
2020 Q3 | 1.00 USD | 0.0% |
2019 Q3 | 1.00 USD | 0.0% |
2019 Q1 | 1.00 USD | 0.0% |
2019 FY | - USD | 0.0% |
2019 Q4 | - USD | -100.0% |
2019 Q2 | - USD | -100.0% |
2018 Q2 | 1.00 USD | 0.0% |
2018 Q1 | 1.00 USD | 0.0% |
2018 FY | - USD | 0.0% |
2018 Q3 | - USD | -100.0% |
2018 Q4 | 1.00 USD | 0.0% |
2017 Q1 | - USD | -100.0% |
2017 Q3 | 1.00 USD | 0.0% |
2017 Q4 | 1.00 USD | 0.0% |
2017 FY | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2016 Q4 | 1.00 USD | -100.0% |
2016 Q1 | 388.1 Thousand USD | 18.53% |
2016 Q3 | 536.09 Thousand USD | 9.69% |
2016 FY | - USD | -100.0% |
2016 Q2 | 488.75 Thousand USD | 25.94% |
2015 FY | 327.44 Thousand USD | -13.04% |
2015 Q3 | 601.66 Thousand USD | 10.73% |
2015 Q4 | 327.44 Thousand USD | -45.58% |
2015 Q2 | 543.38 Thousand USD | 23.88% |
2015 Q1 | 438.61 Thousand USD | 16.49% |
2014 Q1 | 351.4 Thousand USD | 20.02% |
2014 Q4 | 376.52 Thousand USD | -19.79% |
2014 Q3 | 469.44 Thousand USD | 15.63% |
2014 Q2 | 405.99 Thousand USD | 15.53% |
2014 FY | 376.52 Thousand USD | 28.6% |
2013 Q1 | 252.57 Thousand USD | 20.34% |
2013 Q3 | 365.09 Thousand USD | 20.05% |
2013 Q4 | 292.79 Thousand USD | -19.8% |
2013 FY | 292.79 Thousand USD | 39.51% |
2013 Q2 | 304.12 Thousand USD | 20.41% |
2012 FY | 209.87 Thousand USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2012 Q4 | 209.87 Thousand USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2011 Q2 | - USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2010 FY | - USD | 0.0% |
2010 Q3 | 1 Million USD | 8.65% |
2010 Q4 | - USD | -100.0% |
2010 Q2 | 922.41 Thousand USD | 8.83% |
2010 Q1 | 847.6 Thousand USD | 0.0% |
2009 Q2 | 1.38 Million USD | -12.2% |
2009 Q4 | - USD | -100.0% |
2009 Q1 | 1.57 Million USD | 0.0% |
2009 FY | - USD | 0.0% |
2009 Q3 | 1.11 Million USD | -19.1% |
2008 FY | - USD | 0.0% |
2008 Q4 | - USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2008 Q1 | - USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2007 Q3 | - USD | 0.0% |
2007 Q2 | - USD | 0.0% |
2007 Q1 | - USD | 0.0% |
2007 FY | - USD | 0.0% |
2007 Q4 | - USD | 0.0% |
2006 Q2 | - USD | 0.0% |
2006 FY | - USD | 0.0% |
2006 Q4 | - USD | 0.0% |
2006 Q3 | - USD | 0.0% |
2006 Q1 | - USD | 0.0% |
2005 FY | - USD | 0.0% |
2005 Q2 | - USD | 0.0% |
2005 Q1 | - USD | 0.0% |
2005 Q4 | - USD | 0.0% |
2005 Q3 | - USD | 0.0% |
2004 Q3 | - USD | 0.0% |
2004 Q2 | - USD | 0.0% |
2004 Q1 | - USD | 0.0% |
2004 FY | - USD | 0.0% |
2004 Q4 | - USD | 0.0% |
2003 FY | - USD | 0.0% |
2003 Q2 | - USD | 0.0% |
2003 Q3 | - USD | 0.0% |
2003 Q4 | - USD | 0.0% |
2003 Q1 | - USD | 0.0% |
2002 FY | - USD | -100.0% |
2002 Q1 | 336.31 Thousand USD | -7.85% |
2002 Q2 | 308.51 Thousand USD | -8.27% |
2002 Q3 | - USD | -100.0% |
2002 Q4 | - USD | 0.0% |
2001 Q1 | 400.04 Thousand USD | 0.89% |
2001 Q2 | 413.73 Thousand USD | 3.42% |
2001 Q3 | 461.98 Thousand USD | 11.66% |
2001 FY | 364.98 Thousand USD | -7.95% |
2001 Q4 | 364.98 Thousand USD | -21.0% |
2000 FY | 396.49 Thousand USD | -0.88% |
2000 Q4 | 396.49 Thousand USD | -5.86% |
2000 Q3 | 421.17 Thousand USD | -8.57% |
2000 Q1 | 457.26 Thousand USD | 14.32% |
2000 Q2 | 460.65 Thousand USD | 0.74% |
1999 FY | 400 Thousand USD | -20.0% |
1999 Q1 | 500 Thousand USD | 0.0% |
1999 Q2 | 500 Thousand USD | 0.0% |
1999 Q4 | 400 Thousand USD | -20.0% |
1999 Q3 | 500 Thousand USD | 0.0% |
1998 Q1 | 500 Thousand USD | 0.0% |
1998 FY | 500 Thousand USD | 0.0% |
1998 Q4 | 500 Thousand USD | 25.0% |
1998 Q3 | 400 Thousand USD | 0.0% |
1998 Q2 | 400 Thousand USD | -20.0% |
1997 Q2 | 400 Thousand USD | 0.0% |
1997 Q3 | 500 Thousand USD | 25.0% |
1997 FY | 500 Thousand USD | 150.0% |
1997 Q1 | 400 Thousand USD | 100.0% |
1997 Q4 | 500 Thousand USD | 0.0% |
1996 Q1 | 200 Thousand USD | -33.33% |
1996 Q2 | 200 Thousand USD | 0.0% |
1996 FY | 200 Thousand USD | -33.33% |
1996 Q4 | 200 Thousand USD | -33.33% |
1996 Q3 | 300 Thousand USD | 50.0% |
1995 Q2 | 100 Thousand USD | 0.0% |
1995 FY | 300 Thousand USD | 50.0% |
1995 Q3 | 200 Thousand USD | 100.0% |
1995 Q4 | 300 Thousand USD | 50.0% |
1995 Q1 | 100 Thousand USD | -50.0% |
1994 Q3 | 100 Thousand USD | -50.0% |
1994 Q1 | 100 Thousand USD | 0.0% |
1994 FY | 200 Thousand USD | 100.0% |
1994 Q2 | 200 Thousand USD | 100.0% |
1994 Q4 | 200 Thousand USD | 100.0% |
1993 Q1 | 100 Thousand USD | 0.0% |
1993 Q2 | 100 Thousand USD | 0.0% |
1993 Q3 | 100 Thousand USD | 0.0% |
1993 Q4 | 100 Thousand USD | 0.0% |
1993 FY | 100 Thousand USD | 0.0% |
1992 FY | 100 Thousand USD | 0.0% |
1992 Q1 | 100 Thousand USD | 0.0% |
1992 Q4 | 100 Thousand USD | 0.0% |
1991 Q4 | 100 Thousand USD | 0.0% |
1991 Q1 | 100 Thousand USD | 0.0% |
1991 FY | 100 Thousand USD | 0.0% |
1990 Q4 | 100 Thousand USD | 0.0% |
1990 FY | 100 Thousand USD | 0.0% |
1989 Q2 | - USD | 0.0% |
1989 FY | - USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Aclaris Therapeutics, Inc. | - USD | -Infinity% |
Applied DNA Sciences, Inc. | 330.02 Thousand USD | 100.0% |
Aspira Women's Health Inc. | 227 Thousand USD | 100.0% |
Biodesix, Inc. | 1.4 Million USD | 100.0% |
BioNexus Gene Lab Corp. | 1.13 Million USD | 100.0% |
bioAffinity Technologies, Inc. | 18.48 Thousand USD | 99.995% |
bioAffinity Technologies, Inc. | 18.48 Thousand USD | 99.995% |
Bionano Genomics, Inc. | 22.89 Million USD | 100.0% |
CareDx, Inc | 19.47 Million USD | 100.0% |
Check-Cap Ltd. | - USD | -Infinity% |
Castle Biosciences, Inc. | 7.94 Million USD | 100.0% |
DarioHealth Corp. | 5.06 Million USD | 100.0% |
Exact Sciences Corporation | 127.47 Million USD | 100.0% |
Fulgent Genetics, Inc. | 5.82 Million USD | 100.0% |
Guardant Health, Inc. | 61.94 Million USD | 100.0% |
ICON Public Limited Company | 1.00 USD | 0.0% |
IDEXX Laboratories, Inc. | 380.28 Million USD | 100.0% |
Illumina, Inc. | 587 Million USD | 100.0% |
Intelligent Bio Solutions Inc. | 777.53 Thousand USD | 100.0% |
iSpecimen Inc. | - USD | -Infinity% |
Standard BioTools Inc. | 20.53 Million USD | 100.0% |
MDxHealth SA | 2.77 Million USD | 100.0% |
23andMe Holding Co. | 12.46 Million USD | 100.0% |
Medpace Holdings, Inc. | 1.00 USD | 0.0% |
Myriad Genetics, Inc. | 20.1 Million USD | 100.0% |
Mainz Biomed B.V. | 613.63 Thousand USD | 100.0% |
ENDRA Life Sciences Inc. | 2.62 Million USD | 100.0% |
NeoGenomics, Inc. | 24.15 Million USD | 100.0% |
Neogen Corporation | 189.26 Million USD | 100.0% |
Inotiv, Inc. | 56.1 Million USD | 100.0% |
Natera, Inc. | 40.75 Million USD | 100.0% |
OpGen, Inc. | 1.00 USD | 0.0% |
OPKO Health, Inc. | 65.69 Million USD | 100.0% |
Prenetics Global Limited | 3.12 Million USD | 100.0% |
Prenetics Global Limited | 3.12 Million USD | 100.0% |
Precipio, Inc. | 384 Thousand USD | 100.0% |
Personalis, Inc. | 5.66 Million USD | 100.0% |
RadNet, Inc. | 1.00 USD | 0.0% |
Sera Prognostics, Inc. | - USD | -Infinity% |
Sotera Health Company | 51.98 Million USD | 100.0% |
Neuronetics, Inc. | 8.09 Million USD | 100.0% |
Star Equity Holdings, Inc. | 3.42 Million USD | 100.0% |
Star Equity Holdings, Inc. | 3.42 Million USD | 100.0% |
Trinity Biotech plc | 19.93 Million USD | 100.0% |
T2 Biosystems, Inc. | 4.81 Million USD | 100.0% |
Twist Bioscience Corporation | 32.06 Million USD | 100.0% |
Exagen Inc. | 2.87 Million USD | 100.0% |